Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hydration Pharmaceuticals Co. Ltd. ( (AU:HPC) ) has issued an announcement.
Hydration Pharmaceuticals Co. Ltd. announced a change in the director’s interest notice for Nicholas Berry, following the issuance of shares to Pure Asset Management as part of a recent entitlement offer. The company acknowledged a late lodgement of the notice due to an administrative oversight, but assured stakeholders that this was an isolated incident and that they are committed to compliance with ASX listing rules.
More about Hydration Pharmaceuticals Co. Ltd.
Hydration Pharmaceuticals Co. Ltd., also known as Hydralyte USA, operates in the pharmaceutical industry, focusing on hydration solutions. The company is listed on the ASX and engages in the development and distribution of products aimed at maintaining optimal hydration levels for consumers.
Average Trading Volume: 518,000
Technical Sentiment Signal: Sell
For an in-depth examination of HPC stock, go to TipRanks’ Stock Analysis page.